valine has been researched along with Vascular Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, H; Jin, D; Miyazaki, M; Sakonjo, H; Takai, S | 1 |
| Iijima, H; Imasawa, M; Kubota, T; Mabuchi, F; Sakurada, Y; Tanabe, N; Tateno, Y | 1 |
| Janic, M; Lunder, M; Sabovic, M | 1 |
| Aritomi, S; Jin, D; Miyazaki, M; Niinuma, K; Takai, S | 1 |
| Ayala, JM; Azimzadeh, AM; DeMartino, JA; Iliff, S; Kawka, DW; Lu, M; Lyons, K; Miller, GG; Mills, SG; Mudgett, JS; Nguyen, BN; Peterson, LB; Pierson, RN; Schröder, C; Siciliano, SJ; Singer, II; Springer, MS; Wu, G; Zhang, T | 1 |
1 trial(s) available for valine and Vascular Diseases
| Article | Year |
|---|---|
Reduction of age-associated arterial wall changes by low-dose valsartan.
Topics: Adult; Age Factors; Aging; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Brachial Artery; Carotid Artery, Common; Double-Blind Method; Heart Rate; Humans; Male; Pulse Wave Analysis; Slovenia; Tetrazoles; Time Factors; Treatment Outcome; Ultrasonography; Valine; Valsartan; Vascular Diseases; Vascular Stiffness; Vasodilation | 2012 |
4 other study(ies) available for valine and Vascular Diseases
| Article | Year |
|---|---|
Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats.
Topics: Acetylcholine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Carotid Arteries; Hypertension; Imidazoles; Immunohistochemistry; In Vitro Techniques; Male; Muscle Relaxation; NADPH Oxidases; Peptidyl-Dipeptidase A; Protective Agents; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Renin; Reverse Transcriptase Polymerase Chain Reaction; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Tetrazoles; Valine; Valsartan; Vascular Diseases | 2009 |
Role of complement factor H I62V and age-related maculopathy susceptibility 2 A69S variants in the clinical expression of polypoidal choroidal vasculopathy.
Topics: Adult; Age of Onset; Alanine; Choroid; Choroid Diseases; Choroidal Neovascularization; Chromatography; Complement Factor H; Cross-Sectional Studies; Fundus Oculi; Gene Frequency; Genetic Variation; Genotype; Heterozygote; Homozygote; Humans; Incidence; Isoleucine; Phenotype; Polyps; Proteins; Retinal Detachment; Retinal Hemorrhage; Retinal Pigment Epithelium; Serine; Valine; Vascular Diseases | 2011 |
Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats.
Topics: Aldehydes; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Carotid Arteries; Cysteine Proteinase Inhibitors; Dihydropyridines; Heart; Immunohistochemistry; Male; Muscle Relaxation; Muscle, Smooth, Vascular; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Nitric Oxide Synthase Type III; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Real-Time Polymerase Chain Reaction; Tetrazoles; Valine; Valsartan; Vascular Diseases | 2013 |
CCR5 blockade modulates inflammation and alloimmunity in primates.
Topics: Animals; Antibody Formation; Autoimmunity; CCR5 Receptor Antagonists; Cyclosporine; Disease Models, Animal; Graft Survival; Heart Transplantation; HIV Infections; Humans; Immunosuppressive Agents; Inflammation; Isoantibodies; Kidney Transplantation; Macaca fascicularis; Macrophages; Male; Pyrazoles; Stress, Physiological; T-Lymphocytes; Transplantation Tolerance; Transplantation, Homologous; Valine; Vascular Diseases | 2007 |